Tony R. Hunter
Salk Institute for Biological Studies
Public scientific profile · Unclaimed
Built from public scholarly sources. Expertise is inferred by ScienceWe from publications and has not been confirmed by the scientist.
Top expertise
Cancer, Hypoxia, and Metabolism
Strong evidence · 1 supporting paper · latest 2025
Advanced Proteomics Techniques and Applications
Strong evidence · 4 supporting papers · latest 2025
Biochemical and Molecular Research
Strong evidence · 1 supporting paper · latest 2025
PI3K/AKT/mTOR signaling in cancer
Strong evidence · 1 supporting paper · latest 2025
Genomics and Phylogenetic Studies
Strong evidence · 1 supporting paper · latest 2024
Machine Learning in Bioinformatics
Strong evidence · 1 supporting paper · latest 2024
Cancer, Lipids, and Metabolism
Strong evidence · 1 supporting paper · latest 2025
Hepatitis C virus research
Strong evidence · 1 supporting paper · latest 2025
Publications (10)
PI3Kβ functions as a protein kinase to promote cellular protein O-GlcNAcylation and acetyl-CoA production for tumor growth
2025DOIPMID 40132583
π-HuB: the proteomic navigator of the human body
2024DOIPMID 39663494
PIN1 Prolyl Isomerase Promotes Initiation and Progression of Bladder Cancer through the SREBP2-Mediated Cholesterol Biosynthesis Pathway
2025DOIPMID 39808064
Author Correction: π-HuB: the proteomic navigator of the human body
2024DOIPMID 39715925
LHPP expression in triple-negative breast cancer promotes tumor growth and metastasis by modulating the tumor microenvironment
2025DOIPMID 41343666
Using phage display for rational engineering of a higher-affinity humanized 3’ phosphohistidine-specific antibody
2025DOIPMID 41310398
The epidermal growth factor receptor—the prototypic RTK—turns 40
2026DOIPMID 42656153
HDAC inhibition sensitizes pancreatic tumors to DNA damage by global redistribution of the transcriptional machinery
2026DOIPMID 42348617
Interactions between cancer cells and immune cells drive transitions to mesenchymal-like states in glioblastoma
2025DOIPMID 40436018
Supplementary Report from PIN1 Prolyl Isomerase Promotes Initiation and Progression of Bladder Cancer through the SREBP2-Mediated Cholesterol Biosynthesis Pathway
2025DOI
Organizations in sourced records
Affiliation evidence only — not confirmed current employment.
- Salk Institute for Biological Studies
Source: OpenAlex · retrieved 2026-09-29